Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma
β Scribed by Ye-Qin Yu; Dong-Bo Xu; Xin-Da Zhou; Ji-Zhen Lu; Zhao-You Tang; Peter Mack
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 403 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Risk factors for recurrence after resection of hepatitis b virus (hbv)-related hepatocellular carcinoma (hcc) require more precise definition. ## Methods: Forty patients who underwent liver resection for hbv-related hcc were studied. their clinical findings, laboratory data (includ
## BACKGROUND. This study was performed to clarify the clinicopathologic features of hepatocellular carcinoma (HCC) patients surviving ΟΎ10 years after hepatic resection. ## METHODS. Between January 1971 and April 1987, 142 patients underwent hepatic resection. Thirty-nine patients who died of s
## BACKGROUND. Transcatheter arterial chemoembolization (TACE) has been used as a palliative treatment for patients with unresectable hepatocellular carcinoma (HCC), but its prognostic usefulness has not previously been clarified. ## METHODS. The authors reviewed all patients treated at their ins